Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page
- Check2 days agoChange DetectedA site-wide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434.SummaryDifference0.7%

- Check9 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe ClinicalTrials.gov page now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry v3.7.0 was added to the study's history and the previous entry v3.6.6 was removed. This indicates the study record has been updated to a newer revision within the history timeline.SummaryDifference0.1%

- Check59 days agoChange DetectedA new Revision: v3.6.6 entry was added to the version history, and the previous Revision: v3.6.5 entry was removed. This reflects an update to the page metadata rather than substantive trial data.SummaryDifference0.1%

- Check73 days agoChange DetectedThe record history shows a new revision entry updating from v3.6.4 to v3.6.5, indicating a metadata update to the ClinicalTrials.gov record. This change reflects an administrative update rather than new or modified trial data.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.